Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica
Published in:

21-01-2024 | Migraine | Review article

Effect of different non-pharmacologic placebo treatments on migraine prevention: a network meta-analysis of randomized controlled trials

Authors: Yan-Bing Huang, Lu Yuan, Xin-Yu Xiao, Xiao-Ying Wang, Si-Jia Feng, Hui Zheng

Published in: Acta Neurologica Belgica | Issue 4/2024

Login to get access

Abstract

Background

Placebo control plays an important role in evaluating the effectiveness of interventions. Specifying differential effects of various placebo controls on migraine prevention would be essential in the explanation of preventive treatment for migraine and the indirect comparison between different prophylactic therapeutics.

Objectives

To access the impact of different non-pharmacologic placebo types on different outcomes in migraine patients.

Methods

We searched PubMed, Cochrane Controlled Register of Trials, Embase, and Web of Science databases from the date of creation to June 19, 2023. Randomized controlled trials of migraine that included sham intervention of acupuncture or cognitive behavioural therapy (CBT) or non-invasive Vagus Nerve Stimulation (nVNS) or repetitive Transcranial Magnetic Stimulation (rTMS) or transcranial Direct Current Stimulation (tDCS) were conducted. The primary outcome was the migraine days, and the secondary outcomes were the number of migraine attacks, headache days, headache frequency, and responder’s rate. Placebo effects were assessed using five individual placebos for network meta-analysis, using mean differences to measure the relative effect of pair-wise comparisons between interventions.

Result

A total of 50 trials with 4880 subjects were included. Twenty-seven trials were evaluated for low risk of bias. The results of indirect comparisons show that sham rTMS and sham tDCS had optimal and similar effects in reducing migraine days; sham acupuncture has the greatest effect on reducing the number of migraine attacks and relieving headache frequency; sham rTMS had a highly significant advantage in reducing headache days compared with the other placebo controls.

Conclusion

Based on the network meta-analysis results, we found that sham acupuncture had the greatest effect on migraine prophylaxis. The strong placebo effect of sham acupuncture should be considered when assessing the therapeutic effect.
Appendix
Available only for authorised users
Literature
1.
Kaptchuk TJ, Goldman P, Stone DA, Stason WB (2000) Do medical devices have enhanced placebo effects? J Clin Epidemiol 53:786–792PubMedCrossRef
2.
de Craen AJ, Tijssen JG, de Gans J, Kleijnen J (2000) Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 247:183–188PubMedCrossRef
3.
Kaptchuk TJ, Stason WB, Davis RB, Legedza ART, Schnyer RN, Kerr CE, Stone DA, Nam BH, Kirsch I, Goldman RH (2006) Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ 332:391–397PubMedPubMedCentralCrossRef
4.
Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J (2001) Influence of context effects on health outcomes: a systematic review. Lancet 357:757–762PubMedCrossRef
5.
Bergmann JF, Chassany O, Gandiol J, Deblois P, Kanis JA, Segrestaa JM, Caulin C, Dahan R (1994) A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal 29:41–47PubMed
6.
Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, Schneider A, Antes G, Linde K (2013) Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med 173:1941–1951PubMedCrossRef
7.
GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459–480CrossRef
8.
Whyte CA, Tepper SJ (2009) Adverse effects of medications commonly used in the treatment of migraine. Expert Rev Neurother 9:1379–1391PubMedCrossRef
9.
Ashina M, Buse DC, Ashina H, Pozo-Rosich P, Peres MFP, Lee MJ, Terwindt GM, Halker Singh R, Tassorelli C, Do TP, Mitsikostas DD, Dodick DW (2021) Migraine: integrated approaches to clinical management and emerging treatments. Lancet 397:1505–1518PubMedCrossRef
10.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71PubMedPubMedCentralCrossRef
11.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Bias Methods Group, and Cochrane Statistical Methods Group (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928PubMedPubMedCentralCrossRef
12.
13.
Linde M, Fjell A, Carlsson J, Dahlöf C (2005) Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study. Cephalalgia 25:41–47PubMedCrossRef
14.
Calhoun AH, Ford S (2007) Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache 47:1178–1183PubMedCrossRef
15.
Wickmann F, Stephani C, Czesnik D, Klinker F, Timäus C, Chaieb L, Paulus W, Antal A (2015) Prophylactic treatment in menstrual migraine: a proof-of-concept study. J Neurol Sci 354:103–109PubMedCrossRef
16.
Mansourishad H, Togha M, Borjali A, Karimi R (2017) Effectiveness of mindfulness-based cognitive-behavioral therapy on relieving migraine headaches. Arch Neurosci (in Press)
17.
Li Y, Zheng H, Witt CM, Roll S, Yu S, Yan J, Sun G, Zhao L, Huang W, Chang X, Zhang H, Wang D, Lan L, Zou R, Liang F (2012) Acupuncture for migraine prophylaxis: a randomized controlled trial. CMAJ 184:401–410PubMedPubMedCentralCrossRef
18.
Linde K, Streng A, Jürgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melchart D (2005) Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293:2118–2125PubMedCrossRef
19.
Diener H-C, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch H-J, Zenz M, Meinert R, GERAC Migraine Study Group (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5:310–316PubMedCrossRef
20.
Wang Y, Xue CC, Helme R, Da Costa C, Zheng Z (2015) Acupuncture for frequent migraine: a randomized, patient/assessor blinded, controlled trial with one-year follow-up. Evid Based Complement Altern Med 2015
21.
Zhao L, Liu J, Zhang F, Dong X, Peng Y, Qin W, Wu F, Li Y, Yuan K, von Deneen KM, Gong Q, Tang Z, Liang F (2014) Effects of long-term acupuncture treatment on resting-state brain activity in migraine patients: a randomized controlled trial on active acupoints and inactive acupoints. PLoS ONE 9:e99538PubMedPubMedCentralCrossRef
22.
Zhao L, Chen J, Li Y, Sun X, Chang X, Zheng H, Gong B, Huang Y, Yang M, Wu X, Li X, Liang F (2017) The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial. JAMA Intern Med 177:508–515PubMedCrossRef
23.
Xu S, Yu L, Luo X, Wang M, Chen G, Zhang Q, Liu W, Zhou Z, Song J, Jing H, Huang G, Liang F, Wang H, Wang W (2020) Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ 368:m697PubMedPubMedCentralCrossRef
24.
Wallasch T-M, Weinschuetz T, Mueller B, Kropp P (2012) Cerebrovascular response in migraineurs during prophylactic treatment with acupuncture: a randomized controlled trial. J Altern Complement Med 18:777–783PubMedCrossRef
25.
Alecrim-Andrade J, Maciel-Júnior JA, Carnè X, Severino Vasconcelos GM, Correa-Filho HR (2008) Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up. Clin J Pain 24:98–105PubMedCrossRef
26.
Alecrim-Andrade J, Maciel JA Jr, Cladellas XC, Correa-Filho HR, Machado HC (2006) Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia 26:520–529PubMedCrossRef
27.
Diener H-C, Goadsby PJ, Ashina M, Al-Karagholi MA-M, Sinclair A, Mitsikostas D, Magis D, Pozo-Rosich P, Irimia Sieira P, Làinez MJ, Gaul C, Silver N, Hoffmann J, Marin J, Liebler E, Ferrari MD (2019) Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia 39:1475–1487PubMedPubMedCentralCrossRef
28.
Najib U, Smith T, Hindiyeh N, Saper J, Nye B, Ashina S, McClure CK, Marmura MJ, Chase S, Liebler E, Lipton RB (2022) Non-invasive vagus nerve stimulation for prevention of migraine: the multicenter, randomized, double-blind, sham-controlled PREMIUM II trial. Cephalalgia 42:560–569PubMedCrossRef
29.
Zhang Y, Huang Y, Li H, Yan Z, Zhang Y, Liu X, Hou X, Chen W, Tu Y, Hodges S, Chen H, Liu B, Kong J (2021) Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study. Reg Anesth Pain Med 46:145–150PubMedCrossRef
30.
Leahu P, Bange M, Ciolac D, Scheiter S, Matei A, Gonzalez-Escamilla G, Chirumamilla VC, Groppa SA, Muthuraman M, Groppa S (2021) Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation. Brain Stimul 14:1544–1552PubMedCrossRef
31.
Teepker M, Hötzel J, Timmesfeld N, Reis J, Mylius V, Haag A, Oertel WH, Rosenow F, Schepelmann K (2010) Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia 30:137–144PubMedCrossRef
32.
Amin R, Emara T, Ashour S, Hemeda M, Salah Eldin N, Hamed S, Shouman S, Shouman M (2020) The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis. Egypt J Neurol Psychiatr Neurosurg 56:1–6CrossRef
33.
De Icco R, Putortì A, De Paoli I, Ferrara E, Cremascoli R, Terzaghi M, Toscano G, Allena M, Martinelli D, Cosentino G, Grillo V, Colagiorgio P, Versino M, Manni R, Sances G, Sandrini G, Tassorelli C (2021) Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: a pilot double-blind randomized sham-controlled trial. Clin Neurophysiol 132:126–136PubMedCrossRef
34.
Antal A, Kriener N, Lang N, Boros K, Paulus W (2011) Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia 31:820–828PubMedCrossRef
35.
Pohl H, Moisa M, Jung H-H, Brenner K, Aschmann J, Riederer F, Ruff CC, Schoenen J, Luechinger R, Widmer L, Petersen JA, Gantenbein AR, Sandor PS, Michels L (2021) Long-term effects of self-administered transcranial direct current stimulation in episodic migraine prevention: results of a randomized controlled trial. Neuromodulation 24:890–898PubMedCrossRef
36.
Grazzi L, Usai S, Bolognini N, Grignani E, Sansone E, Tramacere I, Maravita A, Lauria G (2020) No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: a double blind, randomised clinical trial. Cephalalgia 40:1202–1211PubMedCrossRef
37.
Foroughipour M, Golchian AR, Kalhor M, Akhlaghi S, Farzadfard MT, Azizi H (2014) A sham-controlled trial of acupuncture as an adjunct in migraine prophylaxis. Acupunct Med 32:12–16PubMedCrossRef
38.
Shah J, Dhull P, Somasekharan M, Soni R, Gupta S (2022) Repetitive transcranial magnetic stimulation for prophylactive treatment of chronic migraine: a randomised, single-blind, parallel-group, sham-controlled trial. Neurol Asia 27:137–144CrossRef
39.
Hodaj H, Payen J-F, Mick G, Vercueil L, Hodaj E, Dumolard A, Noëlle B, Delon-Martin C, Lefaucheur J-P (2022) Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial. Brain Stimul 15:441–453PubMedCrossRef
40.
Rocha S, Melo L, Boudoux C, Foerster Á, Araújo D, Monte-Silva K (2015) Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: a pilot randomized controlled trial. J Neurol Sci 349:33–39PubMedCrossRef
41.
Bäcker M, Grossman P, Schneider J, Michalsen A, Knoblauch N, Tan L, Niggemeyer C, Linde K, Melchart D, Dobos GJ (2008) Acupuncture in migraine: investigation of autonomic effects. Clin J Pain 24:106–115PubMedCrossRef
42.
Li Z, Zeng F, Yin T, Lan L, Makris N, Jorgenson K, Guo T, Wu F, Gao Y, Dong M, Liu M, Yang J, Li Y, Gong Q, Liang F, Kong J (2017) Acupuncture modulates the abnormal brainstem activity in migraine without aura patients. Neuroimage Clin 15:367–375PubMedPubMedCentralCrossRef
43.
Martin PR, Aiello R, Gilson K, Meadows G, Milgrom J, Reece J (2015) Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: an exploratory randomized controlled trial. Behav Res Ther 73:8–18PubMedCrossRef
44.
Martin PR, Forsyth MR, Reece J (2007) Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behav Ther 38:350–363PubMedCrossRef
45.
Kumar A, Mattoo B, Bhatia R, Kumaran S, Bhatia R (2021) Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study. Neurol Sci 42:131–139PubMedCrossRef
46.
Brighina F, Piazza A, Vitello G, Aloisio A, Palermo A, Daniele O, Fierro B (2004) rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci 227:67–71PubMedCrossRef
47.
AbdElkader AA, Fahmy EM, Ahmad AAF, Labib AA, El-Mekkawy LA, El Razek SMA (2021) The efficacy of repetitive transcranial magnetic stimulation in treating patients with chronic daily headache. Egypt J Neurol Psychiatr Neurosurg 57:1–7CrossRef
48.
Sahu AK, Sinha VK, Goyal N (2018) Effect of adjunctive intermittent theta burst repetitive trans cranial magnetic stimulation (ITBS) as a prophylactic treatment in migraine patients: a randomized double blind sham controlled study. Indian J Psychiatry 60:S65
49.
Misra UK, Kalita J, Bhoi SK (2013) High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study. J Neurol 260:2793–2801PubMedCrossRef
50.
Rahimi MD, Fadardi JS, Saeidi M, Bigdeli I, Kashiri R (2020) Effectiveness of cathodal tDCS of the primary motor or sensory cortex in migraine: a randomized controlled trial. Brain Stimul 13:675–682PubMedCrossRef
51.
Rahimi M, Kheirkhah M, Fadardi J (2023) Efficacy of tDCS in chronic migraine: A multiprotocol randomized controlled trial. Clin Neurophysiol 150:119–130CrossRef
52.
Cerrahoğlu Şirin T, Aksu S, Hasirci Bayir BR, Ulukan Ç, Karamürsel S, Kurt A, Baykan B (2021) Is allodynia a determinant factor in the effectiveness of transcranial direct current stimulation in the prophylaxis of migraine? Neuromodulation 24:899–909PubMedCrossRef
53.
Dalla Volta G, Marceglia S, Zavarise P, Antonaci F (2020) Cathodal tDCS guided by thermography as adjunctive therapy in chronic migraine patients: a sham-controlled pilot study. Front Neurol 11:121PubMedPubMedCentralCrossRef
54.
Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, Punjaruk W, Thinkhamrop B, Auvichayapat N (2012) Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. J Med Assoc Thai 95:1003–1012PubMed
55.
Aksu S, Şirin TC, Hasırcı Bayır BR, Ulukan Ç, Soyata AZ, Kurt A, Karamürsel S, Baykan B (2022) Long-term prophylactic transcranial direct current stimulation ameliorates allodynia and improves clinical outcomes in individuals with migraine. Neuromodulation S1094–7159(22):00759
56.
Liu J, Mu J, Liu Q, Dun W, Zhang M, Tian J (2017) Brain structural properties predict psychologically mediated hypoalgesia in an 8-week sham acupuncture treatment for migraine. Hum Brain Mapp 38:4386–4397PubMedPubMedCentralCrossRef
57.
Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, Simmons KA, Mullin C, Liebler EJ, Goadsby PJ, Saper JR, EVENT Study Group (2016) Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study. Neurology 87:529–538PubMedPubMedCentralCrossRef
58.
Soleimanian-Boroujeni F, Badihian N, Badihian S, Shaygannejad V, Gorji Y (2022) The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study. BMC Neurol 22:230PubMedPubMedCentralCrossRef
59.
Cousins S, Ridsdale L, Goldstein LH, Noble AJ, Moorey S, Seed P (2015) A pilot study of cognitive behavioural therapy and relaxation for migraine headache: a randomised controlled trial. J Neurol 262:2764–2772PubMedPubMedCentralCrossRef
60.
Smitherman TA, Walters AB, Davis RE, Ambrose CE, Roland M, Houle TT, Rains JC (2016) Randomized controlled pilot trial of behavioral insomnia treatment for chronic migraine with comorbid insomnia. Headache 56:276–291PubMedCrossRef
61.
Granato A, Fantini J, Monti F, Furlanis G, Ilbeh S, Semenic M, Manganotti P (2019) Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache. J Clin Neurosci 60:96–100PubMedCrossRef
62.
Conforto AB, Amaro E, Gonçalves AL, Mercante JP, Guendler VZ, Ferreira JR, Kirschner CC, Peres MF (2014) Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia 34:464–472PubMedCrossRef
63.
Walach H (2001) The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med 7:213–218PubMedCrossRef
64.
Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JPA, Thabane L, Gluud L-L, Als-Nielsen B, Gluud C (2009) Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol 38:276–286PubMedCrossRef
65.
Trikalinos TA, Churchill R, Ferri M, Leucht S, Tuunainen A, Wahlbeck K, Ioannidis JPA, EU-PSI project (2004) Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. J Clin Epidemiol 57:1124–1130PubMedCrossRef
66.
Ioannidis J, Lau J (2001) Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proc Natl Acad Sci USA 98:831–836PubMedPubMedCentralCrossRef
67.
Metadata
Title
Effect of different non-pharmacologic placebo treatments on migraine prevention: a network meta-analysis of randomized controlled trials
Authors
Yan-Bing Huang
Lu Yuan
Xin-Yu Xiao
Xiao-Ying Wang
Si-Jia Feng
Hui Zheng
Publication date
21-01-2024
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 4/2024
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-023-02460-2

Other articles of this Issue 4/2024

An unexpected etiology of cerebrospinal fluid leak post-transsphenoidal surgery

Beyond skin deep: shedding light on the neuropsychiatric consequences of Monkeypox (Mpox)

Crossed cerebellar Diaschisis in mesial temporal sclerosis: a rare clinical entity

  • Neuro-Images

Marked hypertrophy trigeminal nerves in CIDP: a rare cause of VI nerve compression

Tacrolimus-induced cognitive impairment: a case report

Atypical presentations in an RTD patient and report of novel SLC52A3 and SLC52A2 mutations

How can you integrate PET into your practice? (Link opens in a new window)

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video
Image Credits